Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome
Authors:
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 71, 10-22
Abstract
No abstract availableKeywords
Funding Information
- National Research Fund of Hungary (T100687, K112629)
- Alexion Pharmaceuticals Inc
This publication has 67 references indexed in Scilit:
- Recessive mutations in DGKE cause atypical hemolytic-uremic syndromeNature Genetics, 2013
- Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsPediatric Nephrology, 2012
- Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating ActivitiesJournal of Biological Chemistry, 2011
- Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndromeKidney International, 2010
- Using SIFT and PolyPhen to Predict Loss-of-Function and Gain-of-Function MutationsGenetic Testing and Molecular Biomarkers, 2010
- Genetics and complement in atypical HUSPediatric Nephrology, 2010
- Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic SyndromeJournal of Biological Chemistry, 2009
- Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor BProceedings of the National Academy of Sciences, 2009
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007